EMERGING STRATEGIES TO ENHANCE ORAL BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUGS: FROM BCS CLASSIFICATION TO ADVANCED DELIVERY SYSTEMS

Read full text Summarise with VIRAT
Authors: Kumbhar Dnyaneshwari Vitthal*, Khandagale Pranoti Abaso, Lavand Yash Vishal, Vagare Dnyaneshwari Balasaheb
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Pharmaceutical nanotechnology has emerged as a powerful approach in modern drug development, addressing critical limitations associated with conventional drug delivery systems such as poor solubility, low bioavailability, and systemic toxicity. Lipid-based and polymeric nanocarriers have gained significant importance due to their ability to enhance drug stability, improve targeted delivery, and provide controlled release. Lipid nanocarriers, including liposomes, solid lipid nanoparticles (SLNs), and nanostructured lipid carriers (NLCs), offer excellent biocompatibility and high drug encapsulation efficiency. Polymeric nanocarriers such as polymeric nanoparticles, micelles, and dendrimers enable sustained release and site-specific targeting. These systems significantly improve therapeutic outcomes while reducing adverse effects and enhancing patient compliance. This review discusses classification, mechanisms, advantages, applications, and future prospects of lipid and polymeric nanocarriers in pharmaceutical sciences. Keywords: Pharmaceutical nanotechnology, Lipid nanocarriers, Polymeric nanoparticles, Targeted drug delivery, Controlled release, Drug development

Fields of Study & Subjects

Drug Solubulity and Delivery Systems Advanced Drug Delivery Systems Nanoparticle-Based Drug Delivery

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
22 March 2026
Language
EN